Navigation Links
Covidien Announces New Source of Vital Medical Isotopes
Date:2/17/2010

WARSAW, Poland, February 17, 2010 /PRNewswire-FirstCall/ --

- Addition of Polish Research Reactor Helps With Worldwide Supply Shortage

Covidien (NYSE: COV), a leading global provider of healthcare products, and the Institute of Atomic Energy in Poland (IAE POLATOM) today announced an agreement to augment and further diversify Covidien's supply of Molybdenum 99 (Mo 99) to produce the medical isotope Technetium 99m (Tc 99m).

Tc 99m is a vital medical isotope used in over 80 percent of all nuclear medicine diagnostic and functional studies of organs and anatomical systems. The information from these studies is used by many medical specialists (including radiologists, nephrologists, oncologists and cardiologists) to better diagnose and treat patients. More than 35 million nuclear medicine procedures are performed worldwide each year, more than half in the United States.

Adding the IAE POLATOM'S Maria Research Reactor to Covidien's global supply chain is expected to help Covidien meet the needs of more than one million additional patients in just the first six months after the reactor begins supplying Mo 99.

"This is an historic agreement. It is the first time in decades that a new reactor has been brought into the global supply chain for medical isotopes," said Timothy R. Wright, President, Pharmaceuticals, Covidien. "We are excited that we will now be working together to provide more than a million patients around the globe with access to a critical medical isotope during this serious shortage."

The announcement comes two days before the High Flux Reactor (HFR) in Pett
'/>"/>

SOURCE Covidien
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Frost & Sullivan Recognizes Covidien for Its CT Contrast Delivery System With RFID Enabled Intelligence
2. Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2009 Financial Results Teleconference and Webcast
3. Encorium Group, Inc. Announces One-for-Eight Reverse Stock Split
4. GenomeQuest Announces Boston Seminar: Sequence Data Management for Next Generation Sequencing
5. CoAxia Announces Completion of Enrollment in Ischemic Stroke Trial
6. 3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results
7. Kendle Announces Details Regarding Fourth Quarter and Full-Year 2009 Earnings Conference Call and Webcast
8. Moleac Announces Breakthrough Results on Neuroprotective and Neurogenerative Properties of NeuroAiD
9. Intellect Neurosciences, Inc. Announces Preliminary Agreement with Significant Shareholders to Provide Interim Funding and Assist the Company in Efforts to Secure Additional Financing
10. Kinexus Announces the Launch of a New Protein Kinase Microarray
11. Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 30, 2015 Sanofi, un ... ses résultats pour le premier semestre 2015. Le ... résultats. Visionner l,interview vidéo et lire ... Au sommaire de l,interview :  ... de croissance - Diabète ...
(Date:7/29/2015)... July 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... Company,s Chief Financial Officer has resigned.  The Company has ... Officer who retired in December 2014, as full time ... permanent successor.     Andy Ashworth began ... ensure a smooth transition.  Andy was the Company,s CFO ...
(Date:7/29/2015)... DUBLIN , July 29, 2015 ... ) has announced the addition of the ... to their offering. The Global Biosimilars ... study of the rapidly growing biosimilars market. With ... industry striving to minimize costs, biosimilars are being ...
(Date:7/29/2015)... July 29, 2015  Pfenex Inc. (NYSE MKT: PFNX) ... will be released on Thursday, August 13, 2015, before ... Pfenex management will host a conference call to discuss ... press release outlining the financial results and business update ... Please call 1-866-376-8058 (US) or 1-412-542-4131 (international) and ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2
... on the road. Convinced that American companies are shipping too ... bus tour called Show Us the Jobs . , ... sites were among the 51 people who toured Wisconsin and ... Bush administration to promote a growing economy. , ,Make no ...
... any fan of the Wisconsin Film Festival , waiting ... is inevitably a frustrating part of the process. However, thanks ... festivals Web site, this year moviegoers will experience technological improvements ... Internet development firm IMS , the system is designed ...
... they knew about the work of the Wisconsin Legislature ... likely include God, guns and gays, alliterative shorthand for ... marriage. , ,While those issues commanded the heaviest headlines, ... the recently completed session of the Legislature. The real ...
Cached Biology Technology:Theres a surprising, and positive, side to the offshore jobs debate 2Theres a surprising, and positive, side to the offshore jobs debate 3Wisconsin Film Festival embraces new online ticket ordering system 2Wisconsin Film Festival embraces new online ticket ordering system 3Despite the three Gs, the Wisconsin Legislature had a productive session 2Despite the three Gs, the Wisconsin Legislature had a productive session 3
(Date:7/2/2015)... Research and Markets( ... "Natural Language Processing Market by Type (Rule-Based, ... & Image Recognition) - Worldwide Forecast to 2020" ... key vendors occupying the market are 3M, Apple, ... NetBase Solutions, SAS Institute Inc., Verint Systems among ...
(Date:6/30/2015)... To bolster its efforts and commitment to fighting cyber fraud, ... of two new team members. Dimitri ... Raviv will act as head of strategic alliances. These ... the most secure solutions for the enterprise market. ... a provider of security and management products, which was acquired ...
(Date:6/26/2015)... , June 26, 2015 ATL Technology, LLC, a ... with specialties in single use solutions, headquartered in ... Inc. (a California corporation with locations ... San Jose, Costa Rica ). This ... Rica with ATL Technology,s existing facility in ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2
... drug developed at the University of California, Davis to ... of human clinical trials to evaluate its efficacy. ... inhibitor, is "a first-in-class drug which may treat a ... Bruce Hammock, who with UC Berkeley cell biologist Sarjeet ...
... PITTSBURGH, March 26 Mutations in a gene may cause ... diseases such as chronic obstructive pulmonary disease (COPD) later in ... of Public Health and the German Research Center for Environmental ... measured expression levels of the gene and its variants in ...
... Ann Arbor, MI and Munich (Germany) March 26, ... solutions for the analysis of Next Generation Sequencing (NGS) ... Pathology (MCTP) at the University of Michigan installed a ... (GGA) at its labs in Ann Arbor, MI. GMS ...
Cached Biology News:UC Davis bench-to-bedside research: Promising treatment in clinical trials 2UC Davis bench-to-bedside research: Promising treatment in clinical trials 3UC Davis bench-to-bedside research: Promising treatment in clinical trials 4UC Davis bench-to-bedside research: Promising treatment in clinical trials 5Changes in gene may stunt lung development in children 2MCTP bought Genomatix NextGen Sequencing analysis stations 2
Rabbit polyclonal to SERHL ( Abpromise for all tested applications). entrezGeneID: 94009 SwissProtID: Q9H4I8...
... (Ser385) Immunogen: ... acid region encompassing the human, ... Accession Number: ... Quality Assurance: Routinely evaluated ...
Mouse monoclonal [YLI-90] to Ly49I (Biotin) ( Abpromise for all tested applications)....
TNR-R2...
Biology Products: